288 related articles for article (PubMed ID: 30555488)
1. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.
Thakur A; Rodríguez-Rodríguez C; Saatchi K; Rose F; Esposito T; Nosrati Z; Andersen P; Christensen D; Häfeli UO; Foged C
Front Immunol; 2018; 9():2825. PubMed ID: 30555488
[TBL] [Abstract][Full Text] [Related]
2. Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.
Thakur A; Pinto FE; Hansen HS; Andersen P; Christensen D; Janfelt C; Foged C
Front Immunol; 2020; 11():803. PubMed ID: 32457748
[TBL] [Abstract][Full Text] [Related]
3. Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to
Riccomi A; Piccaro G; Christensen D; Palma C; Andersen P; Vendetti S
Front Immunol; 2019; 10():934. PubMed ID: 31130946
[TBL] [Abstract][Full Text] [Related]
4. Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
Thakur A; Ingvarsson PT; Schmidt ST; Rose F; Andersen P; Christensen D; Foged C
Vaccine; 2018 May; 36(23):3331-3339. PubMed ID: 29699790
[TBL] [Abstract][Full Text] [Related]
5. Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection.
Woodworth JS; Christensen D; Cassidy JP; Agger EM; Mortensen R; Andersen P
Mucosal Immunol; 2019 May; 12(3):816-826. PubMed ID: 30760832
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function.
Müllertz OAO; Andersen P; Christensen D; Foged C; Thakur A
Mol Pharm; 2023 Feb; 20(2):953-970. PubMed ID: 36583936
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
8. Mucosal Delivery of Fusion Proteins with
Copland A; Diogo GR; Hart P; Harris S; Tran AC; Paul MJ; Singh M; Cutting SM; Reljic R
Front Immunol; 2018; 9():346. PubMed ID: 29593708
[TBL] [Abstract][Full Text] [Related]
9. Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.
Platteel ACM; Nieuwenhuizen NE; Domaszewska T; Schürer S; Zedler U; Brinkmann V; Sijts AJAM; Kaufmann SHE
Front Immunol; 2017; 8():1744. PubMed ID: 29312295
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
[TBL] [Abstract][Full Text] [Related]
11. Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System.
Ciabattini A; Pettini E; Fiorino F; Lucchesi S; Pastore G; Brunetti J; Santoro F; Andersen P; Bracci L; Pozzi G; Medaglini D
Front Immunol; 2018; 9():380. PubMed ID: 29593710
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting.
Santoro F; Pettini E; Kazmin D; Ciabattini A; Fiorino F; Gilfillan GD; Evenroed IM; Andersen P; Pozzi G; Medaglini D
Front Immunol; 2018; 9():1248. PubMed ID: 29922291
[TBL] [Abstract][Full Text] [Related]
13. Toll like-receptor agonist Pam
Kennerknecht K; Noschka R; Löffler F; Wehrstedt S; Pedersen GK; Mayer D; Grieshober M; Christensen D; Stenger S
Med Microbiol Immunol; 2020 Apr; 209(2):163-176. PubMed ID: 32020284
[TBL] [Abstract][Full Text] [Related]
14. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
Front Immunol; 2018; 9():2371. PubMed ID: 30386336
[TBL] [Abstract][Full Text] [Related]
15. Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis.
Nandakumar S; Kannanganat S; Dobos KM; Lucas M; Spencer JS; Amara RR; Plikaytis BB; Posey JE; Sable SB
Sci Rep; 2016 May; 6():25837. PubMed ID: 27173443
[TBL] [Abstract][Full Text] [Related]
16. Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung.
Woodworth JS; Cohen SB; Moguche AO; Plumlee CR; Agger EM; Urdahl KB; Andersen P
Mucosal Immunol; 2017 Mar; 10(2):555-564. PubMed ID: 27554293
[TBL] [Abstract][Full Text] [Related]
17. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
[TBL] [Abstract][Full Text] [Related]
18. T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.
Lindenstrøm T; Moguche A; Damborg M; Agger EM; Urdahl K; Andersen P
EBioMedicine; 2018 Jan; 27():27-39. PubMed ID: 29249639
[TBL] [Abstract][Full Text] [Related]
19. Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.
Zhang Y; Guo X; Guo M; Chen X; Li B; Yu J; Gu T; Kong W; Wu Y
Immunol Res; 2019 Oct; 67(4-5):398-407. PubMed ID: 31773490
[TBL] [Abstract][Full Text] [Related]
20. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
Elvang T; Christensen JP; Billeskov R; Thi Kim Thanh Hoang T; Holst P; Thomsen AR; Andersen P; Dietrich J
PLoS One; 2009; 4(4):e5139. PubMed ID: 19357780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
